![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » PICCHIO PHARMA INC. EXERCISES WARRANT TO ACQUIRE 2,800,000 ADDITIONAL SHARES OF NEUROCHEM, INC. (NRMX)
PICCHIO PHARMA INC. EXERCISES WARRANT TO ACQUIRE 2,800,000 ADDITIONAL SHARES OF NEUROCHEM, INC. (NRMX)
July 26, 2005
P.P. Luxco Holdings II s.a.r.l., a wholly-owned subsidiary of Picchio Pharma Inc., announced today that it has exercised a warrant to acquire an additional 2,800,000 common shares of Neurochem Inc., representing approximately 7.5% of the issued and outstanding common shares of Neurochem Inc. after giving effect to the exercise of the warrant.
BioSpace (http://www.biospace.com/news_story.cfm?StoryID=20693520&full=1)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct